🔎 Trials Near Me

Akèy › Melanom › Washington › Seattle

Etid klinik pou Melanom nan Seattle, WA

17 etid pou Melanom ap chèche patisipan nan sit nan ak bò kote Seattle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • ak 1 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

Ap rekriteFaz 2
  • Fred Hutchinson Cancer Center ( Site 4041), Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06961006

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Ap rekriteFaz 3
  • Swedish Cancer Institute, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06246916

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Ap rekriteFaz 3
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center - Montlake, Seattle
  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 17 mi lwen
Laj 75 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07068074

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Ap rekriteFaz 1/2
  • University of Washington Fred Hutchinson Cancer Center, Seattle
Laj 18 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT06814496

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Ap rekriteFaz 2
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04511013

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Seattle Children's Hospital, Seattle
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

Ap rekrite
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT06298734

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Ap rekriteFaz 1
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT05098210

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Ap rekriteFaz 1/2
  • Virginia Mason Medical Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT05379985

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Ap rekriteFaz 1/2
  • Fred Hutchinson Cancer Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT03686124

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • Kaiser Permanente Washington, Seattle
  • Swedish Medical Center-First Hill, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Ap rekriteFaz 3
  • Fred Hutchinson Cancer Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT05549297

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Seattle
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Ap rekriteFaz 2
  • Fred Hutchinson Cancer Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Dec 19, 2024 · NCT06281678

Etid Melanom nan lòt vil

Lòt etid nan Seattle

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.